Cite

HARVARD Citation

    Smoot, K. et al. (2021). Clinical outcomes of patients with multiple sclerosis treated with ocrelizumab in a US community MS center: an observational study. BMJ neurology open. 3 (2), p. . [Online]. 
  
Back to record